The role of CDH1 in OD risk identified here is corroborated by our finding that rare non-silent CDH1 variants predicted to be deleterious were also observed in tumor DNA of 6% of ODs, WHO grade II/III. The gene discussed is CDH1; the disease is osteochondritis dissecans.